Literature DB >> 32042620

Non-muscle invasive bladder cancer cystoscopic surveillance: from overuse to underuse and non-adherence impact.

Leonardo O Reis1.   

Abstract

Entities:  

Year:  2019        PMID: 32042620      PMCID: PMC6989867          DOI: 10.21037/tau.2019.10.05

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN: 2223-4683


× No keyword cloud information.
  14 in total

1.  Prognostic impact of non-adherence to follow-up cystoscopy in non-muscle-invasive bladder cancer (NMIBC).

Authors:  Jean Carlo F Datovo; Wilmar Azal Neto; Gustavo B Mendonça; Danilo L Andrade; Leonardo O Reis
Journal:  World J Urol       Date:  2019-02-25       Impact factor: 4.226

2.  Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006.

Authors:  Matthew E Nielsen; Angela B Smith; Anne-Marie Meyer; Tzy-Mey Kuo; Seth Tyree; William Y Kim; Matthew I Milowsky; Raj S Pruthi; Robert C Millikan
Journal:  Cancer       Date:  2013-10-10       Impact factor: 6.860

3.  The impact of frequent cystoscopy on surgical care and cancer outcomes among patients with low-risk, non-muscle-invasive bladder cancer.

Authors:  Florian R Schroeck; Kristine E Lynch; Zhongze Li; Todd A MacKenzie; David S Han; John D Seigne; Douglas J Robertson; Brenda Sirovich; Philip P Goodney
Journal:  Cancer       Date:  2019-05-23       Impact factor: 6.860

4.  Short term complications from transurethral resection of bladder tumor.

Authors:  Justin R Gregg; Benjamin McCormick; Li Wang; Paul Cohen; Daniel Sun; David F Penson; Joseph A Smith; Peter E Clark; Michael S Cookson; Daniel A Barocas; Matthew J Resnick; Kelvin A Moses; Sam S Chang
Journal:  Can J Urol       Date:  2016-04       Impact factor: 1.344

5.  The effect of surgical duration of transurethral resection of bladder tumors on postoperative complications: An analysis of ACS NSQIP data.

Authors:  Richard S Matulewicz; Vidit Sharma; Barry B McGuire; Daniel T Oberlin; Kent T Perry; Robert B Nadler
Journal:  Urol Oncol       Date:  2015-06-10       Impact factor: 3.498

6.  Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder.

Authors:  B Leblanc; A J Duclos; F Bénard; J Côté; L Valiquette; J M Paquin; F Mauffette; R Faucher; J P Perreault
Journal:  J Urol       Date:  1999-12       Impact factor: 7.450

7.  Prolonging follow-up intervals for non-invasive bladder tumors: a randomized controlled trial.

Authors:  L H Olsen; H G Genster
Journal:  Scand J Urol Nephrol Suppl       Date:  1995

8.  Risk factors for adverse outcomes after transurethral resection of bladder tumors.

Authors:  Brent K Hollenbeck; David C Miller; David Taub; Rodney L Dunn; Shukri F Khuri; William G Henderson; James E Montie; Willie Underwood; John T Wei
Journal:  Cancer       Date:  2006-04-01       Impact factor: 6.860

9.  Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories.

Authors:  Matthew Mossanen; Ye Wang; Julie Szymaniak; Wei Shen Tan; Melissa J Huynh; Mark A Preston; Quoc-Dien Trinh; Guru Sonpavde; Adam S Kibel; Steven L Chang
Journal:  World J Urol       Date:  2018-11-16       Impact factor: 4.226

10.  Patients choose certainty over burden in bladder cancer surveillance.

Authors:  Frits H M van Osch; Duncan Nekeman; Neil K Aaronson; Lucinda J Billingham; Nicholas D James; K K Cheng; Richard T Bryan; Maurice P Zeegers
Journal:  World J Urol       Date:  2019-03-23       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.